KERRIE BAKER: Open Payments
NPI 1326431024 · PORTLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $52 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Novo Nordisk Inc | 3 | $59 |
| Lilly USA, LLC | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| PFIZER INC. | 1 | $17 |
| TOLMAR, INC. | 1 | $14 |
Products named: Kerendia, QULIPTA, VRAYLAR, JOURNAVX, Ozempic, ZEPBOUND, Rybelsus, Wegovy.
Industry payments across TX — which companies pay providers there.
